Document Detail

Combined effect of aerosolized iloprost and oxygen on assessment of pulmonary vasoreactivity in children with pulmonary hypertension.
MedLine Citation:
PMID:  24818629     Owner:  NLM     Status:  Publisher    
OBJECTIVE: The evaluation of pulmonary vascular reactivity plays a significant role in the management of patients with pulmonary hypertension. Inhaled nitric oxide in combination with oxygen (O2) has become widely used as an agent for pulmonary vasodilator testing. However, inhaled nitric oxide is not available in many developing countries. Recently, aerosolized iloprost was suggested as an alternative to nitric oxide for this purpose. In the present study, aerosolized iloprost was used together with O2 in the pulmonary vasoreactivity test of children with severe pulmonary hypertension. Thus, the synergistic effect of both vasodilators was utilized without extending the duration of cardiac catheterization.
METHODS: The prospective cohort study registered a total of 16 children with severe pulmonary hypertension whose median age was 4.5 years. Hemodynamic parameters were quantified before and after the vasoreactivity test. Increased left-to-right shunt, pulmonary vascular resistance of <6 Woods units (WU). /m2 and a pulmonary-systemic resistance ratio of <0.3, as well as a decrease >10% in the pulmonary vascular resistance and pulmonary-systemic vascular resistance ratio after the vasoreactivity test were accepted as a positive response. The data were analyzed using Wilcoxon signed-rank and the Mann-Whitney U tests.
RESULTS: Eleven children gave a positive response to the vasoreactivity test, while 5 children did not respond. Pulmonary vascular resistance dropped from 9.98±1.39 WU./m2 to 5.08±1.05 WU./m2 (p=0.013) and the pulmonary-systemic vascular resistance ratio fell from 0.68±0.08 to 0.32±0.05 (p=0.003) in the children who were responsive. No side effects were observed related to iloprost administration.
CONCLUSION: Administration of inhaled iloprost in combination with O2 for pulmonary vasoreactivity testing can be useful for correctly identifying pulmonary vasoreactivity without extending the duration of cardiac catheterization.
Ozlem Elkıran; Cemşit Karakurt; Gülendam Koçak
Related Documents :
9501819 - Correlation of the anatomical distribution of venous reflux with clinical symptoms and ...
3676569 - Venous lakes: treatment by infrared coagulation.
3989919 - Venous leakage: surgical treatment of a curable cause of impotence.
17538489 - The role of ultrasound in the diagnosis and treatment of chronic venous insufficiency.
7376079 - Surgical correction of chronic deep venous insufficiency by valvular transposition.
16911319 - Venous leg congestion treated with distal venous drainage during peripheral extracorpor...
12957699 - Tlr4 asp299gly polymorphism is not associated with coronary artery stenosis.
2712479 - Retinal periphlebitis after hormonal treatment.
11762529 - Relationships among element contents in the intimal, middle, and external tunicae of th...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-4-16
Journal Detail:
Title:  Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology     Volume:  -     ISSN:  1308-0032     ISO Abbreviation:  Anadolu Kardiyol Derg     Publication Date:  2014 Apr 
Date Detail:
Created Date:  2014-5-13     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101095069     Medline TA:  Anadolu Kardiyol Derg     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Breast arterial calcifications and carotid intima-media thickness and haemodynamics: Is there any as...
Next Document:  Pre-operative high resolution computed tomography scans for cholesteatoma: Has anything changed?